OPRX is trading 5.1% up at $5.15 after Citizens reiterated its bullish rating and the company launched a new AI-powered tool for pharma marketers.

  • Citizens maintained its Market Outperform rating with a $9.00 price target, citing continued growth potential.
  • The company's new AI-powered tool is designed to assist pharmaceutical marketers in optimizing digital campaign performance.
  • The move follows a broader market rebound and extends the positive reaction to news from June 25.